CRP and atherosclerosis: In this study, intensive pitavastatin therapy also showed more favorable effects in reducing the inflammatory or oxidative response, assessed by C reactive protein and MDA-LDL levels [29], which may play a pivotal role in all stages of atherosclerosis.